288 related articles for article (PubMed ID: 16324434)
1. [Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives].
Kjaer A
Ugeskr Laeger; 2005 Nov; 167(48):4549-52. PubMed ID: 16324434
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of cancer using PET and SPECT.
Kjaer A
Adv Exp Med Biol; 2006; 587():277-84. PubMed ID: 17163171
[TBL] [Abstract][Full Text] [Related]
3. PET versus SPECT: strengths, limitations and challenges.
Rahmim A; Zaidi H
Nucl Med Commun; 2008 Mar; 29(3):193-207. PubMed ID: 18349789
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear medicine imaging in neurodegenerative dementias].
Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
[TBL] [Abstract][Full Text] [Related]
5. The future of SPECT in a time of PET.
Jansen FP; Vanderheyden JL
Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025
[TBL] [Abstract][Full Text] [Related]
6. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
7. Small-animal preclinical nuclear medicine instrumentation and methodology.
Rowland DJ; Cherry SR
Semin Nucl Med; 2008 May; 38(3):209-22. PubMed ID: 18396180
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging targeting peptide receptors.
Schottelius M; Wester HJ
Methods; 2009 Jun; 48(2):161-77. PubMed ID: 19324088
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging applications for immunology.
Hildebrandt IJ; Gambhir SS
Clin Immunol; 2004 May; 111(2):210-24. PubMed ID: 15137954
[TBL] [Abstract][Full Text] [Related]
10. Nuclear medicine applications in molecular imaging: 2007 update.
Blankenberg FG; Strauss HW
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):99-110. PubMed ID: 17420712
[TBL] [Abstract][Full Text] [Related]
11. Design considerations for PET/CT tomographs.
Egger M
Nuklearmedizin; 2005; 44 Suppl 1():S63-4. PubMed ID: 16395983
[TBL] [Abstract][Full Text] [Related]
12. Future of nuclear medicine: SPECT versus PET.
Gholamrezanejhad A; Mirpour S; Mariani G
J Nucl Med; 2009 Jul; 50(7):16N-18N. PubMed ID: 19652221
[No Abstract] [Full Text] [Related]
13. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
Culver J; Akers W; Achilefu S
J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
[TBL] [Abstract][Full Text] [Related]
14. Preclinical applications of imaging for cancer gene therapy.
Briat A; Vassaux G
Expert Rev Mol Med; 2006 Jul; 8(16):1-19. PubMed ID: 16842637
[TBL] [Abstract][Full Text] [Related]
15. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
Schillaci O
Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
[TBL] [Abstract][Full Text] [Related]
16. [Clinical applications of molecular imaging methods for patients with ischemic stroke].
Yamauchi H; Fukuyama H
Nihon Rinsho; 2007 Feb; 65(2):315-9. PubMed ID: 17302277
[TBL] [Abstract][Full Text] [Related]
17. Metabolic functional imaging for tumor radiosensitivity monitoring.
Belkacémi Y; Tsoutsou P; Magné N; Castadot P; Azria D
Crit Rev Oncol Hematol; 2007 Jun; 62(3):227-39. PubMed ID: 17241788
[TBL] [Abstract][Full Text] [Related]
18. PET & SPECT instrumentation.
Spanoudaki VC; Ziegler SI
Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine 2020.
Strauss HW
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):1-3. PubMed ID: 16557198
[No Abstract] [Full Text] [Related]
20. The uncertain path to the future of imaging biomarkers.
Nunn AD
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):96-8. PubMed ID: 17420711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
